Windward Bio Announces Pricing of Initial Public Offering
Windward Bio priced its IPO at $17.00 per share, offering 10,294,117 common shares on the Nasdaq Global Select Market under the symbol WWB, with trading expected to begin November 13, 2026. A concurrent private placement of common shares and pre-funded warrants to Sanofi Foreign Participations B.V. brings in an additional $50.0 million, bringing expected gross proceeds to $225.0 million before fees.
Key figures
- Deal Value Usd
- 225000000
- Offering Price
- 17
- Shares Offered
- 10294117
- Private placement value
- 50000000
- Private placement shares
- 1532691
- Pre funded warrant shares
- 1408485
- Underwriter option shares
- 1544117
AI analysis
Red flags3 · Pro
The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.
AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.